• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Top News
    FDA OKs World's First Single-Use Duodenoscope

    Dr. Stephen Hahn Confirmed as New FDA Leader

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

    MedStar Health and Cleveland Clinic Innovations Awarded Grant

    3M to Sell Drug Delivery Business for $650M
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    Adding Fabrication Capabilities: Additive Manufacturing for Production Parts

    Delivering the Goods: The Evolving World of Combination Products

    Anxious Undertones: The 2019 Year in Review

    From Art to Science: The Changing Face of Extrusion

    Exact Science: A Micromolding Roundtable
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    From Genome Sequencing to the World’s First Portable MRI

    An Update on Digital Health

    ‘If You’re Reading This, You Need to Be at This Meeting’

    Five Steps for Succeeding Globally in Medtech

    Unlocking Market Doors with Real-World Evidence
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    MicroLumen Inc.

    GS Plastic Optics

    Lyons

    Carclo Technical Plastics

    Marox Corporation
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    EU's MDR: Irresistible Force Meets Immovable Object

    Ladies First: An Examination of the Women's Health Device Industry

    Localizing Medical Devices

    Sounding Board: Looking Back at 2019 and Gazing at 2020

    Understanding Key Processes for Mixing APIs with Silicone
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    S-Y-M Products Company

    Marox Corporation

    Accumold

    DELMIAWORKS (IQMS)

    Eurofins Medical Device Testing
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • Podcasts
    • Resources
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    Colorado Therapeutics Appoints Former Medtronic Executive as COO

    Company is preparing to launch its first FDA-cleared product, the XI‑S+.

    Related CONTENT
    • Medtronic & Fitbit Partner on New CGM Solution for Simplified Type 2 Diabetes Management
    • FDA Warns of Potential Fires and Explosions From Battery-Powered Medical Carts
    • Medtronic’s CardioInsight Mapping Solution Cleared by FDA
    • FDA OKs Expanded Indication for Medtronic’s Cryoablation Catheter
    • FDA Clears Voxello's Speech Generation Device
    Colorado Therapeutics LLC05.26.17
    Colorado Therapeutics LLC, a commercial-stage medical device company with a proprietary technology platform for the production of innovative cross-linked tissue products, announced that John Lorbiecki has been appointed to the newly created position of chief operating officer effective March 21. Lorbiecki brings broad leadership experience from a career at Medtronic plc in finance, business development and commercial operations to Colorado Therapeutics.
     
    “John’s experience in the areas of marketing, regulatory, reimbursement and financial accounting will be a significant benefit to Colorado Therapeutics as we prepare to launch our first FDA-cleared commercial product, XI‑S+,” said Joseph B. Horn, Colorado Therapeutics’ president and CEO. “His experience with surgical biologics products is particularly applicable to our product line, which has shown utility in the repair of hernia and other soft tissue applications. We welcome John to our team and look forward to capitalizing on his experience with our impending product launch as well as our open Series A financing.”
     
    “From my experience, I believe that the team at Colorado Therapeutics has developed a truly unique biologic tissue product. The characteristics of XI-S+ will provide surgeons with a blend of strength, flexibility, and biocompatibility that is not currently available on the market in either synthetic or biologic products,” Lorbiecki added. “I’ve spent my career at a large, established medical device company. The opportunity to join a nimble, innovative organization at this stage of commercial growth was one I could not pass by.”
     
    During his 25-year career at Medtronic, Lorbiecki held several positions of increasing responsibility, most recently as senior finance director of Strategic Scientific Operations, where he was responsible for developing long-term and annual operating goals, providing business support to clinical, regulatory, reimbursement, and other strategic scientific operations in the company.  Prior to that role,  Lorbiecki held two divisional chief financial officer roles, managed financial integration of multiple acquisitions, and provided analytical and strategic insight on high-value business development opportunities. During his term, he dedicated six years to managing the development of pricing strategy and tactics for the Cardiac Surgery division, including national accounts.  He earned a M.B.A. from the University of Chicago and a bachelor of arts degree in economics from the University of St. Thomas in St. Paul, Minn.
     
    Colorado Therapeutics is a commercial-stage company developing strong, durable and biocompatible tissue from xenogenic sources using a proprietary cross-linked tissue processing technology. Resulting tissue products demonstrate superior benefits compared to currently available biologic or synthetic products. XI-S+, Colorado Therapeutics first commercial product, received U.S. Food and Drug Administration 510(k) clearance in 2016 for implantation to reinforce soft tissue where weakness exists and for the surgical repair of damaged or ruptured soft tissue membranes. Colorado Therapeutics’ products target the $2.25 billion U.S. soft tissue reinforcement and regeneration markets, and may have utility in a broad range of applications. Colorado Therapeutics’ corporate headquarters and pre-commercialization facilities are located in Broomfield, Colo.
    Related Searches
    • tissue
    • surgical
    • medical device company
    • technology
    Suggested For You
    FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers FDA Approval for Medtronic’s MR-Conditional Quadripolar CRT-Pacemakers
    Medtronic Drug-Coated Balloon Demonstrates Consistent Results in Two New Analyses Medtronic Drug-Coated Balloon Demonstrates Consistent Results in Two New Analyses
    FDA Designates N8 Medical FDA Designates N8 Medical's CeraShield Endotracheal Tube as a Breakthrough Device
    Medtronic Launches Advanced StealthStation for Neurosurgery Medtronic Launches Advanced StealthStation for Neurosurgery
    FDA Clears First Whole Slide Imaging System for Digital Pathology FDA Clears First Whole Slide Imaging System for Digital Pathology
    Collaborating on Custom Materials Development Collaborating on Custom Materials Development
    Extractable/Leachable Chemistry Testing Strategies for Medical Devices Extractable/Leachable Chemistry Testing Strategies for Medical Devices
    FDA Clears Medtronic FDA Clears Medtronic's Insertable Cardiac Monitor with TruRhythm Detection
    Balloon Technology Study Launched for Treatment of Below-The-Knee PAD Balloon Technology Study Launched for Treatment of Below-The-Knee PAD
    Four Common Misperceptions of Accelerated FDA Approval Four Common Misperceptions of Accelerated FDA Approval
    FDA Approves Increase in Number of Clinical Sites for E-QURE’s Pivotal Trial of BST Device FDA Approves Increase in Number of Clinical Sites for E-QURE’s Pivotal Trial of BST Device
    Positive Results in Medtronic CRT Reverse Trial Positive Results in Medtronic CRT Reverse Trial
     FlowAid Receives FDA Clearance for the FA100 SCCD FlowAid Receives FDA Clearance for the FA100 SCCD
    CE Mark for Medtronic’s Next Generation CRT Pacemakers CE Mark for Medtronic’s Next Generation CRT Pacemakers
    Capillus Laser Therapy Caps Receive FDA Clearance for Over-the-Counter Use Capillus Laser Therapy Caps Receive FDA Clearance for Over-the-Counter Use

    Related Breaking News

    • Surgical
      FDA OKs World

      FDA OKs World's First Single-Use Duodenoscope

      Boston Scientific's EXALT Model D Duodenoscope eliminates the need for duodenoscope reprocessing and repairs,
      PR Newswire 12.13.19

    • Dr. Stephen Hahn Confirmed as New FDA Leader

      Dr. Stephen Hahn Confirmed as New FDA Leader

      He has never worked in a government position, so his potential FDA agenda is currently unknown.
      Sam Brusco, Associate Editor 12.13.19

    • Diagnostics
      FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

      FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy

      PerkinElmer's test measures dried blood samples collected from the prick of a newborn’s heel 24 to 48 hours after birth.
      U.S. Food and Drug Administration 12.13.19


    • Contract Manufacturing | R&D & Design
      MedStar Health and Cleveland Clinic Innovations Awarded Grant

      MedStar Health and Cleveland Clinic Innovations Awarded Grant

      Cool Idea Award from Protolabs spurs innovation.
      Protolabs 12.12.19

    • 3M to Sell Drug Delivery Business for $650M

      3M to Sell Drug Delivery Business for $650M

      The business, which has annual sales of about $380 million, is being sold to an affiliate of Altaris Capital Partners.
      Business Wire 12.12.19

    • Neurological
      First U.S. Patient Implanted With Axonics

      First U.S. Patient Implanted With Axonics' Sacral Neuromodulation System

      The Axonics r-SNM System is approximately the size of a USB stick and is qualified to operate for at least 15 years.
      Businesswire 12.12.19


    • Cardiovascular
      First U.S. Patients Treated With a Minimally Invasive, Forward Flow Heart Pump

      First U.S. Patients Treated With a Minimally Invasive, Forward Flow Heart Pump

      Impella 5.5 with SmartAssist delivers peak flows of greater than six liters per minute.
      Businesswire 12.12.19

    • Digital Health
      New Pocket Ultrasound Scanners Smaller, More Powerful, and More Affordable

      New Pocket Ultrasound Scanners Smaller, More Powerful, and More Affordable

      Easier to use, second-generation ultra portable wireless scanners give doctors a clearer picture of what's going on.
      PR Newswire 12.12.19

    • Digital Health | Software & IT
      15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

      15-Year Tele-Critical Care Collabration Yields Significant ICU Improvement Results

      Florida’s first eICU, powered by Philips telehealth technology, touts reduced mortality rates and hospital stays for the sickest patients.
      GlobeNewswire 12.11.19


    • 3D/Additive Manufacturing | Software & IT
      Prellis Biologics

      Prellis Biologics' New Tool Simplifies Complex Tissue Engineering

      TissueWorkshop generates complex 3D scaffolds that can be printed with any 3D printing system.
      Krause Taylor Associates 12.11.19

    • InspireMD

      InspireMD's CEO Steps Down

      New CEO Marvin Slosman, a life sciences industry veteran, joins InspireMD from Integra LifeSciences.
      GlobeNewswire 12.11.19

    • Celmatix Sues Research Partner 23andMe for $100M

      Celmatix Sues Research Partner 23andMe for $100M

      Celmatix claims breaches of the parties' agreement and tortious interference with efforts to raise capital.
      PR Newswire 12.11.19

    • FDA Cleared New Cochlear Osia 2 System

      FDA Cleared New Cochlear Osia 2 System

      The world’s first active osseointegrated steady-state implant.
      Cochlear 12.11.19

    • Neurological
      FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

      FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity

      Aptar’s Unidose Liquid System can deliver a formulation in an emergency situation quickly and easily and be administered by a non-healthcare professional.
      Business Wire 12.10.19

    • Diagnostics
      Lens-Free Microendoscope Generates High Quality Images

      Lens-Free Microendoscope Generates High Quality Images

      It also doesn't require movement to focus on objects at different depths.
      Johns Hopkins University 12.10.19


    Breaking News
    • FDA OKs World's First Single-Use Duodenoscope
    • Dr. Stephen Hahn Confirmed as New FDA Leader
    • FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    • MedStar Health and Cleveland Clinic Innovations Awarded Grant
    • 3M to Sell Drug Delivery Business for $650M
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Adding Fabrication Capabilities: Additive Manufacturing for Production Parts
    • Delivering the Goods: The Evolving World of Combination Products
    • Anxious Undertones: The 2019 Year in Review
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.